Gene · 10498
Papers2,160
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,160
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines. | Cell Mol Life Sci | 2025 | 40833497 | PubTator, text mining | PubMed |
| Multifaceted Human Antigen R (HuR): A Key Player in Liver Metabolism and MASLD. | Livers | 2025 | 40809813 | PubTator, text mining | PubMed |
| Therapeutic targeting of protein arginine methyltransferases reduces breast cancer progression by disrupting angiogenic pathways. | Biochem Biophys Rep | 2025 | 40791817 | PubTator, text mining | PubMed |
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| Protein arginine methylation regulates anti-inflammatory programming in response to aging stress. | iScience | 2025 | 40746997 | PubTator, text mining | PubMed |
| Regulation and intervention of stem cell differentiation by long non-coding RNAs: Mechanisms and therapeutic potential. | World J Stem Cells | 2025 | 40740526 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
Correction to "Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities". | J Med Chem | 2025 | 40663778 | PubTator, text mining | PubMed |
| A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway. | Biochem Pharmacol | 2025 | 40619015 | PubTator, text mining | PubMed |
| Coactivator Associated Arginine Methyltransferase 1 Modulates Cartilage Degeneration and Chondrocyte Apoptosis in Osteoarthritis by Regulating ERK1/2 Signaling Pathway. | Aging Cell | 2025 | 40611524 | PubTator, text mining | PubMed |
| Development of a Selective and Potent PRMT4 PROTAC Degrader with Efficacy against Multiple Myeloma in Vitro and in Vivo. | J Med Chem | 2025 | 40531929 | PubTator, text mining | PubMed |
| Emerging roles of protein arginine methyltransferase in multiple myeloma. | Mol Ther Oncol | 2025 | 40524859 | PubTator, text mining | PubMed |
| PRMT4/CARM1 Is a Novel Factor Promoting DNA Double-Strand Break Repair. | Genes Cells | 2025 | 40452456 | PubTator, text mining | PubMed |
| Correction to 'CARM1/PRMT4 facilitates XPF-ERCC1 heterodimer assembly and maintains nucleotide excision repair activity'. | Nucleic Acids Res | 2025 | 40444639 | PubTator, text mining | PubMed |
| CARM1-Mediated MAP2K4 Methylation Potentiates the Oncogenic Functions of MAP2K4 and Constitutes a Targetable Dependency in Triple-Negative Breast Cancer. | Cancer Res | 2025 | 40440094 | PubTator, text mining | PubMed |
| Mapping of the QTLs governing grain nutrients in wheat (Triticum aestivum L.) under nitrogen treatment using high-density SNP markers. | Front Plant Sci | 2025 | 40420860 | PubTator, text mining | PubMed |
| Arginine methylation patterns in LUAD: defining prognostic subtypes and relevance to immunotherapy. | Discov Oncol | 2025 | 40399547 | PubTator, text mining | PubMed |
| A Perspective on the Strategic Application of Deconstruction-Reconstruction in Drug Discovery. | J Med Chem | 2025 | 40324045 | PubTator, text mining | PubMed |
| CARM1/PRMT4 facilitates XPF-ERCC1 heterodimer assembly and maintains nucleotide excision repair activity. | Nucleic Acids Res | 2025 | 40304182 | PubTator, text mining | PubMed |
| TRIB3 recruits and stabilizes CARM1 to confer chemoresistance by activating Akt signalling in clear cell renal cancer cells. | Biochem Biophys Res Commun | 2025 | 40286768 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10498/papers?page=4